AWI vs CAE

AWI's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite strong profitability metrics like a 38.03% ROE and solid earnings growth, elevated valuation multiples and weak insider sentiment weigh on the outlook. The stock trades above its Graham Number of $56.59 and near its intrinsic value estimate of $184.15, suggesting limited margin of safety. Analysts maintain a 'buy' recommendation with a $211.10 target, implying upside, but recent insider selling and deteriorating short-term earnings momentum raise caution.

CAE presents a concerning valuation profile, trading at $25.32 despite a Graham Number of $15.09 and an Intrinsic Value of $6.02. While the Piotroski F-Score of 4/9 indicates stable health, this is offset by critical liquidity risks evidenced by a Current Ratio of 0.91 and a Quick Ratio of 0.65. The company is experiencing a severe earnings contraction of -35.9% YoY, which is fundamentally incompatible with its current P/E of 29.44. Technical trends are entirely bearish (0/100), suggesting a lack of market confidence despite optimistic analyst price targets.